EGFR and lung adenocarcinoma: EGFR-mutant group with resected lung adenocarcinomas has a tendency of lower DFS than the wild-type EGFR group only in stage IIIa, but there was no significant difference for both groups.The EGFR mutation status was not associated with disease-free survival or overall survival in resected lung adenocarcinomas.